Pluristyx-preview

Pluristyx

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://pluristyx.com/

Last Round

Grant

Nov 17, 2025

Company Overview

Pluristyx is a biotechnology company that provides induced pluripotent stem cell (iPSC) products, contract development, and manufacturing services to accelerate the development of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

induced pluripotent stem cellsiPSCscell therapygene editingCDMO servicesoff-the-shelf cell therapyallogeneic cell therapyimmune evasion technologyimmune cloakingcell therapy safety switchkill switch technologyregenerative medicinecell line developmentGMP cell linesCMC supportcellular reprogrammingorganoid productsAI-augmented cell manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluristyx Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pluristyx Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 17, 2025
Convertible Debt	Jul 28, 2025
Early Funding	Dec 21, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Jason Carstens

Chief Operating Officer And Co-Founder, Chairman Of The Board

Founding Team

Benjamin Fryer

Co-Founder And CEO

Founding Team

Priya Baraniak

Chief Commercial And Development Officer, Director, Board Of Directors

Executive Team

Pluristyx Investors

Notable investors and investment history

Investor	Rounds
JDRF	Grant
BroadOak Capital Partners	Early Funding, Convertible Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 19, 2026
Monthly visitors grew 97% MoM, reaching 3.7K.
Jan 27, 2026
Monthly visitors increased 33% MoM.

View all signals

Pluristyx Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pluristyx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pluristyx's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range15

Year Founded2018

Last FundingNov 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.